The attached resource is the cumulative number of PrEP initiations for Q1 of 2023.
Topic(s): Monitoring & Evaluation
Product(s): Oral PrEP
Source(s): AVAC
Type: Document
This document summarises key takeaways from the BioPIC Think Tank held in March 2024 to review existing PrEP evidence and evidence gaps to date.
This article from The Lancet Regional Health- Americas describes trends in PrEP uptake during the first ten years of PrEP provision in the United States by race, ethnicity, sex, and region.
This article from Patient Preference and Adherence describes the results of a qualitative study with female sex workers in Malaysia to assess the potential need for PrEP in this population and the factors that determine willingness to use oral PrEP.
This article from BMC Women’s Health describes the results of a study exploring the views of young women, male partners, and male peers of young women in Siaya County, Western Kenya, to illustrate how men influence, and can support, young women in using PrEP.
This article from Eurosurveillance describes the results of a study comparing rates for chlamydia, gonorrhoea and syphilis before and after PrEP initiation in gay and bisexual men who have sex with men in Denmark.
This article from International Health describes PrEP uptake and 12 month retention amongst gay and bisexual men who have sex with men and transgender women in Myanmar during the covid-19 pandemic and a political crisis and includes insights into user motivations for uptake and continuation.
Evidence shows that offering PrEP is a safe and effective HIV prevention strategy for pregnant and breastfeeding people. Guidance from the World Health Organization (WHO) supports provision of PrEP to pregnant and breastfeeding people (PBFP) who are at continuing substantial risk of HIV infection. Evidence has shown that people have an increased need for HIV…
This market assessment explores the opportunities and barriers to leveraging private sector channels to expand access to new and existing pre-exposure prophylaxis (PrEP) methods, including oral PrEP, the dapivirine vaginal ring (PrEP ring), and long acting cabotegravir (CAB PrEP) in Eswatini.
In this first interim analysis, the MOSAIC team provides key learnings from preparing for the delivery of PrEP choice, a summary of challenges experienced in implementing the enhanced service delivery model and the solutions introduced, programmatic considerations for countries preparing to introduce new PrEP methods, and a list of publicly accessible tools and resources used…
This article from Frontiers in Reproductive Health describes the results of a study to calculate the actual costs of oral PrEP scale-up in ten counties in Kenya, including a comparison of service delivery models across regions. In addition, the study looked at factors that indicate why some individuals place a greater value on PrEP than…
